Report cover image

Enzyme-Linked Immunosorbent Assay Market - 2025-2033

Published Apr 16, 2026
Length 207 Pages
SKU # DTAM21131348

Description

Enzyme-Linked Immunosorbent Assay Market Overview:
The Enzyme-Linked Immunosorbent Assay Market was valued at US$ 2.39 billion in 2025 and is anticipated to reach US$ 3.76 billion by 2033, at a CAGR of 0.058 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Enzyme-Linked Immunosorbent Assay Market.

This report delivers a comprehensive overview of the Enzyme-Linked Immunosorbent Assay Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay Market. The Enzyme-Linked Immunosorbent Assay Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Enzyme-Linked Immunosorbent Assay Market Scope:
By Test Type
• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA

By Product
• Kits & Reagents
• ELISA Analyzers

By Application
• Drug Discovery
• Infectious Diseases
• Cancer Detection
• Protein Quantification
• Others

By End-user
• Hospitals
• Academic and Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Others

Key Players
• Thermo Fisher Scientific, Inc.
• American Laboratory Products Company (ALPCO)
• ZEUS Scientific, Inc.
• Life Technologies Corporation
• Bio-Rad Laboratories, Inc.
• QuidelOrtho Corporation
• bioMerieux S.A.
• Gemelli Biotech
• BD
• Enzo Biochem Inc.

Major Highlights
This report delivers a comprehensive overview of the Enzyme-Linked Immunosorbent Assay Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay Market. The Enzyme-Linked Immunosorbent Assay Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

207 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Test Type
3.2. Snippet by Product
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing incidence of infectious diseases
4.1.2. Restraints
4.1.2.1. Threat of substitution from alternative technologies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Test Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type
6.2. Direct ELISA*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Indirect ELISA
6.4. Sandwich ELISA
6.5. Competitive ELISA
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Kits & Reagents*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. ELISA Analyzers
7.3.1. Automated
7.3.2. Semi-automated
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Infectious Diseases
8.4. Cancer Detection
8.5. Protein Quantification
8.6. Others
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic and Research Institutes
9.4. Pharmaceutical & Biotechnology Companies
9.5. Diagnostic Laboratories
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.3.1. The U.S.
10.2.3.2. Canada
10.2.3.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.3.1. Germany
10.3.3.2. UK
10.3.3.3. France
10.3.3.4. Italy
10.3.3.5. Spain
10.3.3.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.4.1. Brazil
10.4.4.2. Argentina
10.4.4.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.4.1. China
10.5.4.2. India
10.5.4.3. Japan
10.5.4.4. South Korea
10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. American Laboratory Products Company (ALPCO)
12.3. ZEUS Scientific, Inc.
12.4. Life Technologies Corporation
12.5. Bio-Rad Laboratories, Inc.
12.6. QuidelOrtho Corporation
12.7. bioMerieux S.A.
12.8. Gemelli Biotech
12.9. BD
12.10. Enzo Biochem Inc. (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.